0001493152-16-006599.txt : 20160105 0001493152-16-006599.hdr.sgml : 20160105 20160105140616 ACCESSION NUMBER: 0001493152-16-006599 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150109 FILED AS OF DATE: 20160105 DATE AS OF CHANGE: 20160105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences Inc CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knox Thomas J CENTRAL INDEX KEY: 0001520356 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 161321478 MAIL ADDRESS: STREET 1: 1717 ARCH STREET STREET 2: SUITE 3820 CITY: PHILADELPHIA STATE: PA ZIP: 19103 4/A 1 form4a.xml X0306 4/A 2015-01-09 2015-01-09 0 0001321834 Akers Biosciences Inc AKER 0001520356 Knox Thomas J 50 S. 16TH STREET PHILADELPHIA PA 19102 1 0 0 0 Common Stock 2015-01-09 4 A 0 50000 0 A 408150 D Such shares were issued under Akers Biosciences, Inc.'s Amended and Restated 2013 Incentive Stock and Award Plan. The Form 4 filed on January 12, 2015 for Mr. Knox incorrectly listed the amount of common stock beneficially owned as 466,666. At such time, Mr. Knox beneficially owned 408,150 shares of common stock. This amended Form 4 represents the correct total amount of common stock beneficially owned by Mr. Knox as of January 12, 2015. /s/ Thomas J. Knox 2016-01-05